AngioDynamics (ANGO) Earnings Date, Estimates & Call Transcripts → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free ANGO Stock Alerts $6.35 +0.08 (+1.28%) (As of 12:27 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateJul. 10EstimatedActual EPS (Apr. 4) -$0.16 Missed By -$0.02 Consensus EPS (Apr. 4) -$0.14 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANGO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANGO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyKiss of death from Joe BidenIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. AngioDynamics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.14)$0.00($0.09) Q2 20243($0.08)$0.03($0.04) Q3 20243($0.15)$0.03($0.08) Q4 20243($0.21)$0.09($0.07) FY 202412($0.58)$0.15($0.29) Q1 20252($0.19)($0.11)($0.15) Q2 20252($0.17)($0.15)($0.16) Q3 20252($0.16)($0.07)($0.12) Q4 20252($0.12)($0.09)($0.11) FY 20258($0.64)($0.42)($0.53) Q1 20261($0.18)($0.18)($0.18) Q2 20261($0.08)($0.08)($0.08) Q3 20261($0.02)($0.02)($0.02) ANGO Earnings Date and InformationAngioDynamics last announced its earnings results on April 4th, 2024. The medical instruments supplier reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.02. AngioDynamics has generated ($4.84) earnings per share over the last year (($4.84) diluted earnings per share). Earnings for AngioDynamics are expected to decrease in the coming year, from ($0.57) to ($0.58) per share. AngioDynamics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 10th, 2024 based off prior year's report dates.Read More AngioDynamics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/10/2024(Estimated)------- 4/4/2024Q3 2024($0.14)($0.16)($0.02)$4.41--1/5/2024Q2 2024($0.09)($0.05)+$0.04$0.62$81.65 million$79.07 million10/4/2023Q1 2024($0.13)($0.12)+$0.01($1.39)$77.70 million$78.70 million 7/12/2023Q2 2023$0.02$0.02-$0.58$90.73 million$91.10 million 3/30/2023Q3 2023($0.01)($0.03)($0.02)$0.18$83.20 million$80.70 million 1/5/2023Q2 2023($0.01)$0.01+$0.02$0.23$84.05 million$85.43 millionElon Musk’s Final Masterpiece: “X-9840” (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare.10/6/2022Q1 2023($0.02)($0.06)($0.04)$0.21$83.43 million$81.50 million 7/12/2022Q4 2022$0.01$0.01-$0.18$82.91 million$87.00 million 4/7/2022Q3 2022($0.01)$0.03+$0.04$0.19$76.32 million$74.00 million 1/5/2022Q4 2021$0.0050($0.02)($0.0250)$0.17$77.90 million$78.30 million 9/30/2021Q3 2021($0.05)($0.02)+$0.03$0.14$71.31 million$77.00 million 3/29/2021Q1 2021($0.02)$0.02+$0.04$0.13$68.42 million$71.18 million 1/6/2021Q4 2020($0.02)$0.01+$0.03$0.13$67.33 million$72.80 million 10/4/2020Q3 2020($0.07)$0.02+$0.09$0.15$65.10 million$70.20 million 7/16/2020Q2 2020($0.06)($0.06)-$3.98$62.86 million$58.30 million 4/7/2020Q1 2020($0.03)$0.01+$0.04$0.17$68.55 million$69.80 million 1/7/2020Q2 2020$0.02$0.06+$0.04$0.19$71.28 million$70.00 million 10/3/2019Q1 2020$0.04$0.08+$0.04$0.19$67.74 million$66.00 million 7/10/2019Q4 2019$0.26$0.25($0.01)($1.04)$92.34 million$96.30 million AngioDynamics Earnings - Frequently Asked Questions When is AngioDynamics's earnings date? AngioDynamics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 10th, 2024 based off last year's report dates. Learn more on ANGO's earnings history. Did AngioDynamics beat their earnings estimates last quarter? In the previous quarter, AngioDynamics (NASDAQ:ANGO) missed the analysts' consensus estimate of ($0.14) by $0.02 with a reported earnings per share (EPS) of ($0.16). Learn more on analysts' earnings estimate vs. ANGO's actual earnings. How much revenue does AngioDynamics generate each year? AngioDynamics (NASDAQ:ANGO) has a recorded annual revenue of $338.75 million. How much profit does AngioDynamics generate each year? AngioDynamics (NASDAQ:ANGO) has a recorded net income of -$52.44 million. ANGO has generated -$4.84 earnings per share over the last four quarters. What is AngioDynamics's EPS forecast for next year? AngioDynamics's earnings are expected to decrease from ($0.57) per share to ($0.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cytosorbents Earnings Results Orthofix Medical Earnings Results Surmodics Earnings Results Accuray Earnings Results Rockwell Medical Earnings Results ReShape Lifesciences Earnings Results Abbott Laboratories Earnings Results Intuitive Surgical Earnings Results Stryker Earnings Results Boston Scientific Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:ANGO) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesHow Biden has already won 2024Porter & CompanyDems have chosen Biden replacement?Paradigm PressGet out of dollars—get into America’s new money insteadStansberry ResearchMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryElon’s New A.I. Device is About to Shock the WorldInvestorPlaceNYSE biotech company's drug could be as revolutionary as penicillin!Financial Markets DailyThe 1,000X Crypto PlaybookTrue Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding AngioDynamics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
